Tricopharming (Biotech Tricopharming Research) has closed a collaboration agreement with Livisto for the exclusive distribution in Spain of its product Artennua®, 100% vegetable complementary food capsules, which will also be available on the market with a new formulation. The objective of the collaboration is to expand the Artennua® brand throughout Spain, and preserve its identity…
The 5-step formula for profitable veterinary clinics A good veterinarian is a strategist. And thanks to the space granted to me by Artennua on their blog, I’m going to explain why a veterinary clinic is profitable by applying a 5 simple step formula. Before I start, I want to tell you a little story. A…
Watch the CMM Castilla-La Mancha Media interview about our work with Artemisia annua and its possible application in the fight against the virus.
Our company Tricopharming was included by the ABC newspaper in the top of the biotechnology and ICT companies that are committed to development and innovation in Spain thanks to our biotechnology based on biopharmaceutical agriculture and our first success case Artennua®, a optimized version of Artemisia annua. Read the complete ABC newspaper note here.
Glad to announce that Tricopharming has been selected among the 20 most innovative tech startups of Catalonia Region within the framework of the Startup Capital 2019 call! Startup Capital boosts early stage technological companies helping to accelerate their product development and road map to market by co-financing business plan implementation. The call is addressed to…
Our Artennua plant, an optimized version of Artemisia annua is trending thanks to the great potential of its Artemisinin molecule as a possible treatment for Covid-19. Watch at the Radio Television Canaria RTVC note about our work.
Look at the journalistic note of El Economista about the great power of our #Artemisiaannua plant grown on our ecological farm in Tenerife.
Artemisia annua plant contains more than 400 metabolites. Among them, stands out the molecule artemisinin, the most effective antimalarial treatment to date. Could Artemisia annua and/or artemisinin molecule be a good candidate to fight Covid-19? This TV news contributes to the debate with our CEO Luís Matías Hernández, PhD, and our Agricultural Engineer Andrés Acosta…
Thanks to CDTI and our achievement at Cervera project, we have been working on our production platform for biomolecules of Industrial interest. We will continue working on the validation of our biostimulation technology in various species of Medicinal and Aromatic plants (MAPs), as well as we have done with Artemisia annua plant. Learn more about…
Today, on World Entrepreneur Day, we received an amazing news: we are winners of the 23th Canary Islands Entrepreneurship Award by FYDE. The CajaCanaria Bank Foundation supporting the entrepreneurship (Fundación Canaria para la Formación y Desarrollo Empresarial de CajaCanarias) selected the finalists from different islands. The jury was composed by the General Director of the…
